GlassScriptPhysician profile
Bryant J Castelein
NPI 1992110241
$12,683.23
in general payments reported to CMS, 2019-2025
42 companies · $1,733 in 2025
The $1,733 reported for 2025 was more than what 88% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,487 · 2020: $244 · 2021: $609 · 2022: $375 · 2023: $3,536 · 2024: $2,699 · 2025: $1,733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,687 · Travel and Lodging: $2,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,686.67 |
| Travel and Lodging | $2,281.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,700.97 | 2019-2024 | |
| Medwest Associates | $1,653.76 | 2019-2023 | |
| Arthrosurface Incorporated | $1,438.09 | 2019-2025 | Toe Motiontm |
| Lightbody Medical Technologies INC | $1,267.46 | 2024 | |
| Progenacare Global, LLC | $1,047.36 | 2023-2024 | |
| Organogenesis INC. | $929.68 | 2024-2025 | Puraply Wound Matrix, Apligraf, Cygnus Dual |
| Smith+Nephew, INC. | $713.19 | 2019-2025 | Stravix, Collagenase Santyl, Grafix Pl |
| Treace Medical Concepts, INC. | $621.63 | 2022-2025 | |
| Stryker Corporation | $562.57 | 2021-2025 | Ortholoc 2 Lapifuse, Ortholoc 3di Crosscheck, Prophecy |
| Paragon 28, INC. | $396.04 | 2019-2023 | Ttc Nail |
| Wright Medical Technology, INC. | $218.29 | 2019-2020 | |
| Zak Ortho | $197.17 | 2024-2025 | |
| Horizon Therapeutics Plc | $191.59 | 2019-2020 | |
| Vaporox, INC. | $167.00 | 2023 | Vht-200 Wound Treatment System |
| Paratek Pharmaceuticals, INC. | $160.74 | 2024-2025 | Nuzyra |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $156.56 | 2020-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Nevro Corp. | $135.38 | 2022-2024 | Senza |
| Osteomed LLC | $127.06 | 2019-2021 | |
| Kerecis Limited | $122.08 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Pinnacle, INC | $120.56 | 2019 | |
| Integra Lifesciences Corporation | $114.67 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Depuy Synthes Sales INC. | $85.80 | 2025 | Na |
| Convatec INC. | $70.80 | 2025 | |
| Mimedx Group, INC. | $58.11 | 2025 | |
| Orthofix Medical, INC. | $52.48 | 2019-2023 | Physio-Stim |
| Anika Therapeutics, INC. | $42.34 | 2021-2022 | |
| Medtronic, INC. | $32.76 | 2023-2025 | Inceptiv, Endurant Iis |
| Osiris Therapeutics INC. | $30.73 | 2019 | |
| Solventum Corporation | $27.96 | 2025 | Promogran Prisma, Activ.A.C. |
| Ani Pharmaceuticals, INC. | $27.50 | 2025 | Purified Cortrophin Gel |
| Acera Surgical, INC. | $25.61 | 2025 | Restrata Wound Matrix |
| Aroa Biosurgery Incorporated | $24.94 | 2023 | |
| Averitas Pharma INC. | $21.21 | 2023 | Qutenza |
| Melinta Therapeutics, LLC | $20.97 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.34 | 2022 | |
| Ossdsign USA Incorporated | $17.07 | 2025 | Ossdsign Catalyst |
| Pacira Pharmaceuticals Incorporated | $16.60 | 2019 | |
| Tactile Systems Technology INC | $14.75 | 2021 | |
| Medline Industries LP | $13.88 | 2020 | |
| Abbott Laboratories | $13.69 | 2023 | Proclaim |
| Hartmann USA, INC. | $13.25 | 2024 | Zetuvit Plus 10x10 P10 |
| Ermi LLC | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryant Castelein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.